Logo image of INMD

INMODE LTD (INMD) Stock Price, Quote, News and Overview

NASDAQ:INMD - Nasdaq - IL0011595993 - Common Stock - Currency: USD

18.065  +0.57 (+3.23%)

INMD Quote, Performance and Key Statistics

INMODE LTD

NASDAQ:INMD (2/5/2025, 10:50:09 AM)

18.065

+0.57 (+3.23%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High26.8
52 Week Low14.87
Market Cap1.38B
Shares76.25M
Float68.05M
Yearly DividendN/A
Dividend YieldN/A
PE10.15
Fwd PE8.77
Earnings (Next)N/A N/A
IPO08-08 2019-08-08


INMD short term performance overview.The bars show the price performance of INMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5

INMD long term performance overview.The bars show the price performance of INMD in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of INMD is 18.065 USD. In the past month the price increased by 2.88%. In the past year, price decreased by -32.59%.

INMODE LTD / INMD Daily stock chart

INMD Latest News, Press Releases and Analysis

News Image
22 hours ago - Benzinga

US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?

U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.

News Image
a day ago - InMode Ltd.

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial...

News Image
2 days ago - Inmode Ltd

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial...

News Image
a month ago - InMode Ltd.

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its...

News Image
3 months ago - InMode Ltd.

InMode to Present at Upcoming Investor Conferences

/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following...

INMD Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.13 227.85B
ISRG INTUITIVE SURGICAL INC 80.14 209.22B
BSX BOSTON SCIENTIFIC CORP 44.85 156.00B
SYK STRYKER CORP 32.53 151.16B
MDT MEDTRONIC PLC 17.39 117.10B
BDX BECTON DICKINSON AND CO 18.54 70.75B
EW EDWARDS LIFESCIENCES CORP 26.97 42.47B
GEHC GE HEALTHCARE TECHNOLOGY 20.6 39.71B
IDXX IDEXX LABORATORIES INC 41.27 38.01B
RMD RESMED INC 27.58 35.79B
DXCM DEXCOM INC 51.71 34.34B
PHG KONINKLIJKE PHILIPS NVR- NY 20.5 25.62B

About INMD

Company Profile

INMD logo image InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.

Company Info

INMODE LTD

Tavor Building, Sha'ar Yokneam, Pob 533

Yokneam 2069200 IL

CEO: Moshe Mizrahy

Employees: 581

Company Website: https://inmodemd.com/

Investor Relations: https://inmodemd.com/investors/

Phone: 97249097470

INMD FAQ

What is the stock price of INMD?

The current stock price of INMD is 18.065 USD.


What is the symbol for INMODE LTD stock?

The exchange symbol of INMODE LTD is INMD and it is listed on the Nasdaq exchange.


On which exchange is INMD stock listed?

INMD stock is listed on the Nasdaq exchange.


Is INMD a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for INMD, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of INMD.


Does INMD stock pay dividends?

INMD does not pay a dividend.


What is the Price/Earnings (PE) ratio of INMD?

The PE ratio for INMD is 10.15. This is based on the reported non-GAAP earnings per share of 1.78 and the current share price of 18.065 USD.


What is the Short Interest ratio of INMD stock?

The outstanding short interest for INMD is 8.39% of its float.


INMD Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to INMD. When comparing the yearly performance of all stocks, INMD is a bad performer in the overall market: 86.78% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

INMD Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to INMD. INMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INMD Financial Highlights

Over the last trailing twelve months INMD reported a non-GAAP Earnings per Share(EPS) of 1.78. The EPS increased by -30.47% compared to the year before.


Industry RankSector Rank
PM (TTM) 36.26%
ROA 18.65%
ROE 20.85%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-40.85%
Sales Q2Q%-22.82%
EPS 1Y (TTM)-30.47%
Revenue 1Y (TTM)N/A

INMD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 78% to INMD. The Buy consensus is the average rating of analysts ratings from 13 analysts.

For the next year, analysts expect an EPS growth of 15.77% and a revenue growth -0.75% for INMD


Ownership
Inst Owners71.77%
Ins Owners6.86%
Short Float %8.39%
Short Ratio6.58
Analysts
Analysts78.46
Price Target21.25 (17.63%)
EPS Next Y15.77%
Revenue Next Year-0.75%